Disulfidptosis: a new target for central nervous system disease therapy

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• Disulfidptosis is a cell death pathway triggered by NADPH deficiency and excess disulfide bonds, particularly in cells with high SLC7A11 expression.
• Disulfide stress, a form of oxidative stress, is increasingly recognized as a factor in central nervous system (CNS) diseases.
• Existing research links proteins and metabolic pathways involved in disulfidptosis to neurodegenerative diseases, neurogliomas, and ischemic stroke.

Purpose of the Study:

• To provide a comprehensive review of disulfidptosis pathogenesis, including its origins, genetic factors, and signaling pathways.
• To explore the association between disulfide stress, thiometabolism disruption, and CNS diseases.
• To summarize current therapeutic strategies and propose novel treatment targets for CNS disorders.

Main Methods:

• Literature review of existing research on disulfidptosis and CNS diseases.
• Analysis of genetic factors, signaling proteins, and metabolic pathways involved in disulfidptosis.
• Synthesis of information on disulfidptosis-related drugs and potential therapeutic interventions.

Main Results:

• Disruption of thiometabolism and disulfide stress are critical factors in CNS diseases, with disulfidptosis playing a potential role.
• Proteins and metabolic pathways associated with disulfidptosis show significant links to neurodegenerative diseases, neurogliomas, and ischemic stroke.
• A hypothesis for a novel therapeutic target in CNS diseases related to disulfidptosis is proposed.

Conclusions:

• Disulfidptosis is a significant pathological process implicated in the pathogenesis of various CNS diseases.
• Targeting thiometabolism and disulfide stress pathways presents a promising therapeutic avenue for CNS disorders.
• Further research into disulfidptosis mechanisms could lead to the development of effective treatments for neurological conditions.